Skip to content

A Clinical Study on Postoperative Salvage Autotransfusion in Coronary Artery Bypass Grafting

A Clinical Study on Postoperative Salvage Autotransfusion in Coronary Artery Bypass Grafting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103269
Enrollment
Unknown
Registered
2025-05-27
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleeding after coronary artery bypass grafting

Interventions

Postoperative autotransfusion group:Patients in the postoperative autotransfusion group received shed mediastinal blood collected from mediastinal drainage within the first 6 hours after surgery. The
Standard care group:Patients in standard care group had their shed mediastinal blood discarded in accordance with routine clinical practice. Allogeneic RBC transfusion, including the decision to trans

Sponsors

Fuwai Hospital Chinese Academy of Medial Sciences, Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18~70 years; 2. Undergoing isolated CABG (both on-pump and off- pump);

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; 2. Concomitant other types of surgery performed simultaneously; 3. Exclusion of patients requiring re-sternotomy for non-hemorrhagic reasons; 4. Preoperative imaging-confirmed pleural effusion; 5. Active malignancy (diagnosed within 6 months before surgery without completion of radical treatment); 6. Contamination or infection risk present before shed blood reinfusion (e.g., chylothorax, mediastinal infection, or purulent secretion); 7. Occurrence of early severe postoperative complications prior to reinfusion (e.g., postoperative re-sternotomy, acute renal failure) or other conditions deemed by the investigator as unsuitable for enrollment (specific reasons to be documented).

Design outcomes

Primary

MeasureTime frame
Allogeneic RBC transfusion volume postoperatively;

Secondary

MeasureTime frame
Postoperative allogeneic RBC transfusion rate;Incidence of in-hospital composite complications (renal insufficiency, myocardial infarction, cerebral infarction, deep vein thrombosis, respiratory insufficiency, bloodstream infection) and all-cause mortality.;Health Economic Evaluation;

Countries

China

Contacts

Public ContactHongwen Ji

Fuwai Hospital Chinese Academy of Medial Sciences, Shenzhen

13701229553@163.com+86 137 0122 9551

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026